Details for New Drug Application (NDA): 208947
✉ Email this page to a colleague
The generic ingredient in QUETIAPINE FUMARATE is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
Summary for 208947
Tradename: | QUETIAPINE FUMARATE |
Applicant: | Novast Labs |
Ingredient: | quetiapine fumarate |
Patents: | 0 |
Suppliers and Packaging for NDA: 208947
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 208947 | ANDA | Novast Laboratories, Ltd. | 34908-636 | 34908-636-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-636-10) |
QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 208947 | ANDA | Novast Laboratories, Ltd. | 34908-636 | 34908-636-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-636-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Nov 29, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Nov 29, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Nov 29, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription